Codiak BioSciences is a venture-backed start-up dedicated to harnessing the power of exosomes as both therapeutics and diagnostics in cancer and other diseases. Codiak is building a world-class team and has generated, acquired and licensed foundational intellectual property to enable the development of products that capitalize on the unique biology of exosomes.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 11/17/15 | $80,000,000 |
ARCH Venture Partners Flagship Ventures | undisclosed |
